ATE284676T1 - Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen - Google Patents

Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen

Info

Publication number
ATE284676T1
ATE284676T1 AT01989339T AT01989339T ATE284676T1 AT E284676 T1 ATE284676 T1 AT E284676T1 AT 01989339 T AT01989339 T AT 01989339T AT 01989339 T AT01989339 T AT 01989339T AT E284676 T1 ATE284676 T1 AT E284676T1
Authority
AT
Austria
Prior art keywords
drug
precipitation
evaporation
production
aqueous solutions
Prior art date
Application number
AT01989339T
Other languages
English (en)
Inventor
Keith P Johnston
Robert O Williams
Timothy J Young
Xiaoxia Chen
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE284676T1 publication Critical patent/ATE284676T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT01989339T 2000-11-03 2001-10-22 Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen ATE284676T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24547900P 2000-11-03 2000-11-03
US09/808,332 US6756062B2 (en) 2000-11-03 2001-03-14 Preparation of drug particles using evaporation precipitation into aqueous solutions
PCT/US2001/051337 WO2002047659A2 (en) 2000-11-03 2001-10-22 Preparation of drug particles using evaporation precipitation into aqueous solutions

Publications (1)

Publication Number Publication Date
ATE284676T1 true ATE284676T1 (de) 2005-01-15

Family

ID=26937266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01989339T ATE284676T1 (de) 2000-11-03 2001-10-22 Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen

Country Status (8)

Country Link
US (1) US6756062B2 (de)
EP (1) EP1335705B1 (de)
JP (1) JP2004515525A (de)
AT (1) ATE284676T1 (de)
AU (1) AU2002243441A1 (de)
CA (1) CA2427625A1 (de)
DE (1) DE60107872T2 (de)
WO (1) WO2002047659A2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425543B2 (en) * 1992-11-16 2008-09-16 The Corporation Of Mercer University Microencapsulated materials and method of making same
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US8551526B2 (en) * 2000-11-03 2013-10-08 Board Of Regents, The University Of Texas System Preparation of drug particles using evaporation precipitation into aqueous solutions
KR20030074693A (ko) * 2000-12-28 2003-09-19 알투스 바이올로직스 인코포레이티드 전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
NZ530700A (en) * 2001-06-21 2009-02-28 Altus Pharmaceuticals Inc Spherical protein particles and methods of making and using them
CA2450748A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
WO2003032951A1 (en) * 2001-08-29 2003-04-24 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
CA2526454C (en) 2003-05-22 2013-08-13 Applied Nanosystems B.V. Gel-assisted production of small particles
US20050175683A1 (en) * 2003-10-24 2005-08-11 Yuanpeng Zhang Preparation of lipid particles
US7754243B2 (en) * 2004-08-03 2010-07-13 Clemson University Research Foundation Aqueous suspension of nanoscale drug particles from supercritical fluid processing
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
WO2006026502A1 (en) * 2004-08-27 2006-03-09 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
EP1885335A1 (de) * 2005-04-27 2008-02-13 BAXTER INTERNATIONAL INC. (a Delaware corporation) Oberflächenmodifizierte mikroteilchen und verfahren zu ihrer bildung und verwendung
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
IN2015DN00888A (de) 2006-02-22 2015-07-10 Mannkind Corp
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
WO2008060786A2 (en) * 2006-10-06 2008-05-22 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
WO2008065502A1 (en) * 2006-11-29 2008-06-05 Pfizer Products Inc. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
WO2008125940A2 (en) * 2007-04-17 2008-10-23 Pfizer Products Inc. Nanoparticles comprising non-crystalline drug
CN101292958B (zh) * 2007-04-27 2011-04-27 北京化工大学 一种超细达那唑粉体的制备方法
WO2008135852A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Pharmaceutical compositions comprising nanoparticles and casein
US8309129B2 (en) * 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2162120B1 (de) 2007-06-04 2016-05-04 Bend Research, Inc Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
EP2231169B1 (de) 2007-12-06 2016-05-04 Bend Research, Inc. Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
WO2009073216A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
US20100151037A1 (en) * 2008-08-07 2010-06-17 Yivan Jiang Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
SG10202010355PA (en) 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
EP2608772A2 (de) * 2010-08-23 2013-07-03 President and Fellows of Harvard College Partikel für wirkstofffreisetzung und andere anwendung
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2720680B1 (de) 2011-06-17 2020-02-12 Berg LLC Inhalbierbare pharmazeutische zusammensetzungen
WO2012178082A1 (en) * 2011-06-24 2012-12-27 The Trustees Of Columbia University In The City Of New York Improved methods, devices and systems to process x-ray diffraction data
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
KR102047025B1 (ko) * 2019-05-07 2019-12-02 엔젯 주식회사 반도체 패키지의 언더필 방법 및 장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9313650D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
ATE386506T1 (de) * 1995-10-17 2008-03-15 Jagotec Ag Verabreichung unlöslicher arzneistoffe
AU5719798A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes

Also Published As

Publication number Publication date
WO2002047659A3 (en) 2002-09-06
US6756062B2 (en) 2004-06-29
AU2002243441A1 (en) 2002-06-24
US20020081334A1 (en) 2002-06-27
DE60107872D1 (de) 2005-01-20
CA2427625A1 (en) 2002-06-20
EP1335705A2 (de) 2003-08-20
WO2002047659A2 (en) 2002-06-20
JP2004515525A (ja) 2004-05-27
DE60107872T2 (de) 2005-05-19
EP1335705B1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
ATE284676T1 (de) Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen
KR970706799A (ko) 소립자 형성(Small Partical Formation)
ATE249813T1 (de) Einhüllungssverfahren
DK1765294T3 (da) Nukleinsyremikrokugler samt deres fremstilling og afgivelse
EP1127570A3 (de) Verfahren zur Herstellung von wirkstofbeladenen Polymer-Micellen Zusammensetzung
CY1107059T1 (el) Υδατικη διασπορα που περιεχει σταθερα νανοσωματιδια μιας αδιαλυτης στο νερο δραστικης ουσιας κι ενα εκδοχο οπως τα τριγλυκεριδια μεσης αλυσιδας (mct)
ATE294828T1 (de) Neue polythiophen-dispersionen
BR0116377A (pt) Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria
CA2458889A1 (en) A process for preparing crystalline drug particles by means of precipitation
ATE235240T1 (de) Wässriges verfahren zur herstellung fester paroxetin-dispersionen
EP1541637A4 (de) Neues verfahren zur herstellung von pigmentnanopartikulat
EA200000154A1 (ru) Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
WO2006072943A3 (en) Nano- and mesosized particles comprising an inorganic core, process and applications thereof
CA2084452A1 (en) Modified xanthan gum and method for modifying xanthan gum
AU2002233822A1 (en) Oral itraconazole formulations and methods of making the same
WO2002038126A3 (en) A process for production of particles for pharmaceutical compositions having increased bioavailability
RU99100149A (ru) Способ получения водорастворимых производных фуллеренов
CN101530074A (zh) 一种哒螨灵微乳剂的制备方法
ATE416757T1 (de) Herstellung von mikropartikeln
JP2002518348A5 (de)
WO2005015160A3 (en) Functionalized polymeric colloids
EP1240896A3 (de) Einkapseln von wasserlöslischen Peptiden
UA29540C2 (uk) Спосіб одержання молекулярно-колоїдних розчинів фуллеренів у воді

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties